Third quarter 2021 reported and adjusted EPS* were $1.75 and $1.67, respectively, compared to third quarter 2020 reported and adjusted EPS of $1.36 and $1.77, respectively. The Company expects full year 2021 adjusted EPS to be in the range of $6.65-$7.00, up from the previously provided full year outlook of $6.45-$6.85. WESTCHESTER, Ill., Nov. 02, […]

Corporate vision: Sustainably advancing the noble work of global agricultural and construction workers New optimized organizational structure will drive efficiency, agility and accountability Structure enhances customer-centricity and targets digital and technology leadership London, November 2, 2021 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces a new strategic structure as

Barrows, the provider of hotel investments and advisory services to hotels in the Middle East, wants to expand in Asia and Russia; Barrows recently started offering asset based lending to the hotel industry to meet the demand for cash flow freedom; Barrows is in the market for over 10 years

Ideal Systems announces today that it has designed, built and delivered next-generation NDI® based TV studios with 4K live production and streaming capabilities for iFAST Corporation Ltd in Singapore. iFast TV Studio SINGAPORE, Nov. 02, 2021 (GLOBE NEWSWIRE) — Ideal Systems announces today that it has designed, built and delivered

MELBOURNE, Australia, Nov. 01, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Australian Therapeutic Goods Administration (TGA) has approved Illuccix® (TLX591-CDx), the Company’s lead prostate cancer imaging product. Illuccix (Kit for the preparation of 68Ga PSMA-11 Injection) is a positron emission tomography